Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

ClinicalTrials.gov ID: NCT04157686

Public ClinicalTrials.gov record NCT04157686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Long-term, Open-label Study to Evaluate the Safety of MT10109L (NivobotulinumtoxinA) for the Treatment of Glabellar Lines and Lateral Canthal Lines

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the long-term safety of MT10109L in the treatment of GL and/or LCL in participants with moderate to severe GL and/or LCL.

Study identification

NCT ID
NCT04157686
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Medy-Tox
Industry
Enrollment
957 participants

Conditions and interventions

Eligibility (public fields only)

Age range
19 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 23, 2019 (Actual)
Primary completion
Feb 16, 2023 (Actual)
Completion
Feb 16, 2023 (Actual)
Last update posted
Aug 9, 2024

2019 – 2023

United States locations

U.S. sites
18
U.S. states
10
U.S. cities
17
Facility City State ZIP Site status
Clear Dermatology & Aesthetics Center Scottsdale Arizona 85255-4134 —
The Eye Research Foundation Newport Beach California 92663-3637 —
Art of Skin MD Solana Beach California 92075-2228 —
Susan H. Weinkle Bradenton Florida 34209-5642 —
Skin Research Institute Coral Gables Florida 33146-1837 —
Coleman Center For Cosmetic Dermatologic Surgery Metairie Louisiana 70006 —
Etre Cosmetic Dermatology and Laser Center New Orleans Louisiana 70130-4353 —
MD Laser Skin & Vein Hunt Valley Maryland 21030 —
Laser & Skin Surgery Center of New York New York New York 10016-4974 —
Skin Search of Rochester Inc. Rochester New York 14623 —
M3 Wake Research Inc. Raleigh North Carolina 27612-8106 —
Wilmington Dermatology Center Wilmington North Carolina 28403 —
Aventiv Research Dublin Dublin Ohio 43016 —
Westlake Dermatology & Cosmetic Surgery - Westlake Austin Texas 78746-4720 —
DermResearch Inc. Austin Texas 78759 —
Bellaire Dermatology Bellaire Texas 77401 —
SkinDC Arlington Virginia 22209 —
Virginia Clinical Research, Inc. Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04157686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2024 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04157686 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →